Case details

Court: cafc
Docket #: 14-1469
Case Name: Medicines Company v. Hospira, Inc.
PACER case #: 14-1469
Date filed: 2014-05-13
Nature of Suit: 830 Patent Infringement (Fed. Question)

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2014-05-13 1 0 Appeal docketed. Received: 05/09/2014. [153973]Entry of Appearance due 05/27/2014. Certificate of Interest is due on 05/27/2014. Docketing Statement due 05/27/2014. Appellant's brief is due 07/14/2014.
2014-05-27 2 0 Entry of appearance for Edgar H. Haug as principal counsel for Appellant The Medicines Company. Service: 05/27/2014 by email. [157175]
2014-05-27 3 0 Entry of appearance for Porter F. Fleming as of counsel for Appellant The Medicines Company. Service: 05/27/2014 by email. [157176]
2014-05-27 4 0 Entry of appearance for Angus Chen as of counsel for Appellant The Medicines Company. Service: 05/27/2014 by email. [157178]
2014-05-27 5 0 Certificate of Interest for the Appellant The Medicines Company. Service: 05/27/2014 by email. [157179]
2014-05-27 6 0 Docketing Statement for the Appellant The Medicines Company. Service: 05/27/2014 by email. [157180]
2014-05-27 7 0 Notice of intent to file corresponding briefs on CD-ROM for Appellant The Medicines Company. Service: 05/27/2014 by email. [157187]
2014-05-27 8 0 Entry of appearance for Sara T. Horton as principal counsel for Appellee Hospira, Inc.. Service: 05/27/2014 by email. [157192]
2014-05-27 9 0 Entry of appearance for Aaron A. Barlow as of counsel for Appellee Hospira, Inc.. Service: 05/27/2014 by email. [157194]
2014-05-27 10 0 Certificate of Interest for the Appellee Hospira, Inc.. Service: 05/27/2014 by email. [157196]
2014-05-27 11 0 Docketing Statement for the Appellee Hospira, Inc.. Service: 05/27/2014 by email. [157197]
2014-05-27 12 0 Notice of intent to file corresponding briefs on CD-ROM for Appellee Hospira, Inc.. Service: 05/27/2014 by email. [157198]
2014-05-29 15 0 Amended Entry of appearance for Sara T. Horton as of counsel for Cross-Appellant Hospira, Inc.. Service: 05/29/2014 by email. [157776]
2014-05-30 17 0 Notice of Rejection to Cross-Appellant Hospira, Inc., the following document(s) cannot be filed: [16] attorney entry of appearance. Reason(s) There is already a principal attorney on record for this party... [157871]
2014-06-13 18 0 MOTION of Appellant The Medicines Company and Cross-Appellant Hospira, Inc. to extend the time to 08/14/2014 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 06/26/2014, to extend the time to 09/26/2014 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 06/26/2014 [Consent: unopposed]. Service: 06/13/2014 by US mail, email. [161410]
2014-06-20 19 0 ORDER granting motion to extend time to file appellant's initial brief [18] and granting motion to extend time to file cross-appellant's initial brief [18] filed by cross-appellant Hospira, Inc. and appellant The Medicines Company. The appellant's brief is due August 14, 2014 and the cross-appellant's brief is due September 26, 2014. Service: 06/20/2014 by clerk. [162765] 2014-09-15 15:43:38 4ddd6bafeab15f6191dca06812b194518508b67a
2014-06-27 20 0 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant The Medicines Company. Service: 06/27/2014 by email. [163974]
2014-06-27 21 0 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Hospira, Inc.. Service: 06/27/2014 by email. [164040]
2014-08-13 22 0 TENDERED from Appellant The Medicines Company. Title: OPENING BRIEF. Service: 08/13/2014 by email. [174989]
2014-08-14 23 0 BRIEF FILED for Appellant The Medicines Company [22]. Title: OPENING BRIEF. Number of Pages: 153. Service: 08/13/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/25/2014. [175702] 2014-11-15 23:32:25 b9f5cb29f5716059d7c409ccd1da6b3b1ff3510d
2014-09-26 25 0 TENDERED from Cross-Appellant Hospira, Inc.. Title: OPENING BRIEF. Service: 09/26/2014 by email. [185947]
2014-09-26 26 0 BRIEF FILED for Cross-Appellant Hospira, Inc. [25]. Title: OPENING BRIEF. Number of Pages: 73. Service: 09/26/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/07/2014. Appellant's reply brief is due 11/10/2014. [187232] 2014-10-02 18:40:09 2fe247543b523319f89e47188ab2738d0d5648d6
2014-11-10 28 0 TENDERED from Appellant Medicines Company, The. Title: REPLY BRIEF. Service: 11/10/2014 by email. [196600]
2014-11-10 29 0 REPLY BRIEF FILED for Appellant Medicines Company, The [28]. Number of Pages: 64. Service: 11/10/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/18/2014. Cross-Appellant's reply brief is due 12/01/2014. [197233]
2014-11-24 31 0 Amended Certificate of Interest for the Cross-Appellant Hospira, Inc.. Service: 11/24/2014 by email. [199824]
2014-11-26 32 0 ORDER filed. The Medicines Company and Hospira, Inc. are directed to respond [200186-2] [200186-3] no later than seven days of the date of filing of this order. Any reply by Mylan et al. is due no later than three days from the date of service of the response. Service: 11/26/2014 by clerk. [200497] [15-1113, 14-1469]
2014-11-26 33 0 TENDERED from Cross-Appellant Hospira, Inc.. Title: REPLY BRIEF. Service: 11/26/2014 by email. [200538]
2014-11-26 34 0 REPLY BRIEF FILED for Cross-Appellant Hospira, Inc. [33]. Number of Pages: 31. Service: 11/26/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 12/08/2014. Appendix is due 12/08/2014. [201207]
2014-12-03 35 0 RESPONSE of Appellant Medicines Company, The to the clerk order for expedited response or reply [32] ,clerk order to set case manager tickler date [32] ,clerk order [32]. Service: 12/03/2014 by email. [201600]
2014-12-03 36 0 RESPONSE of Cross-Appellant Hospira, Inc. to the clerk order for expedited response or reply [32] ,clerk order to set case manager tickler date [32] ,clerk order [32]. Service: 12/03/2014 by email. [201601]
2014-12-08 38 0 Statement of Compliance with Fed. Cir. R. 33 for Appellant Medicines Company, The and Cross-Appellant Hospira, Inc.. Service: 12/08/2014 by email. [202629]
2014-12-08 39 0 Notice of intent to file corresponding briefs on CD-ROM for Appellant Medicines Company, The. Service: 12/08/2014 by email. [202632]
2014-12-08 40 0 TENDERED from Appellant Medicines Company, The and Cross-Appellant Hospira, Inc.. Title: JOINT APPENDIX. Service: 12/08/2014 by email. [202634]
2014-12-08 42 0 REPLY of Mylan Inc., Mylan Pharmaceuticals Inc., and Bioniche Pharma USA, LLC to response filed by Cross-Appellant in 14-1469 , Doc. No [36], response filed by Appellant in 14-1469 , Doc. No [35]. Service: 12/08/2014 by email. [202670]
2014-12-08 44 0 APPENDIX FILED for Medicines Company, The [40]. Number of Pages: 715. Service: 12/08/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 12/15/2014. [203144]
2014-12-12 46 0 Notice from Appellant Medicines Company, The regarding conflicts with oral argument (February 6, 2015, March 2 through March 6, 2015, and April 6 through April 7, 2015.). Service: 12/12/2014 by email. [203654]
2014-12-16 48 0 Letter from Cross-Appellant Hospira, Inc. re scheduling conflicts re oral argument (Rule 34, Practice Note). Service: 12/16/2014 by email. [204529]
2015-01-06 50 0 ORDER filed. Mylan's motion to expedite and for companion case treatment [200186-3] is denied. Appellants may file their briefs early without leave of court, thereby self-expediting the appeal. Oral argument will be scheduled for the next available argument calendar after the reply brief is filed. No extensions of time should be anticipated. The Medicines Company should calculate the due date for its response brief from the date of filing of this order. The Medicines Company's motion to withdraw [199817-2] is granted, and its motion to dismiss [195144-2] is withdrawn. Service: 01/06/2015 by clerk. [207635] [15-1113, 14-1469]
2015-01-09 51 0 Clerk's Letter to Appellant The Medicines Company and Cross-Appellant Hospira, Inc. (Clerk letter regarding counsel's schedule conflicts). See related entry: [46], [48]. Service as of this date by Clerk of Court. Response due on or before 01/14/2015. [208610]
2015-01-14 52 0 Letter from Appellant Medicines Company, The and Cross-Appellant Hospira, Inc. Response to ECF No. 51. Service: 01/14/2015 by email. [209628]
2015-07-02 58 0 OPINION and JUDGMENT filed. The judgment or decision is: Reversed. (Precedential Opinion). (For the Court: Dyk,Circuit Judge; Wallach,Circuit Judge and Hughes,Circuit Judge). [253168] [14-1469, 14-1504] VACATED PURSUANT TO THE COURT'S ORDER FILED 11/13/15. SEE DOC. NO. [68]
2015-07-31 59 0 Petition for panel rehearing, for en banc rehearing filed by Appellant Medicines Company, The. Service: 07/31/2015 by email. The paper copies of the petition must be filed within two business days (see ECF-10(d)).The required paper copies should be received by the court on or before 08/04/2015 [261271]
2015-08-24 61 0 The court invites a response from Cross-Appellant Hospira, Inc. to the petition for en banc rehearing filed by Appellant in 14-1469. [266474]
2015-09-08 62 0 RESPONSE of Cross-Appellant Hospira, Inc. to the petition for panel rehearing [59] filed by Appellant Medicines Company, The in 14-1469 , petition for en banc rehearing [59] filed by Appellant Medicines Company, The in 14-1469. Service: 09/08/2015 by email. [270377]
2015-09-14 64 0 MOTION of Appellant Medicines Company, The for leave to file a response/reply to [62] response. Response/Opposition is due 09/28/2015 [Consent: opposed]. Service: 09/14/2015 by email. [272038]
2015-09-24 67 0 ORDER filed denying [64] motion to file a response/reply filed by Medicines Company, The. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [274737]
2015-11-13 68 0 PRECEDENTIAL ORDER filed: The petition for rehearing en banc [59] filed by The Medicines Company is granted. The court's opinion of July 2, 2015 [58] is vacated, and the appeal is reinstated. The parties are requested to file new briefs addressing the issues identified in this order. The new en banc briefs shall be electronically filed and 30 paper copies of each brief shall be filed with the court. Hospira, Inc.'s en banc brief is due 45 days from the date of this order. [see order for complete briefing schedule]. Briefing should be limited to the issues set forth in this order. The court invites the United States Department of Justice to file a brief expressing the views of the United States as amicus curiae. Other briefs of amici curiae will be entertained and any such briefs may be filed without consent and leave of court but otherwise must comply with Rule 29. The parties are directed to file with the court 30 paper copies of their original briefs and joint appendix within 17 days. Oral argument may be held at a time and date to be announced later. By: Court En Banc (Per Curiam). Service as of this date by Clerk of Court. [288574] 2015-11-13 14:06:13 f9ff2d865a66199c2dc6b164a198b1b7d6965bbf
2015-11-30 69 0 Entry of appearance for Megan Barbero as principal counsel for Amicus Curiae US. Service: 11/30/2015 by email. [292443]
2015-12-01 70 0 Entry of appearance for Mark R Freeman as of counsel for Amicus Curiae US. Service: 12/01/2015 by email. [292571]
2015-12-10 71 0 MOTION of Appellant The Medicines Company and Cross-Appellant Hospira, Inc. to extend time until 01/11/2016 to file (En Banc Briefs). Response/Opposition is due 12/28/2015 [Consent: unopposed]. Service: 12/10/2015 by email. [295250]
2015-12-14 72 0 ORDER filed granting joint motion to extend time to file en banc briefs [71] filed by Cross-Appellant Hospira, Inc. and Appellant The Medicines Company. The cross-appellant's opening en banc brief due 01/11/2016, and appellant's response en banc brief is due on or before 02/24/2016. By: Per Curiam. Service as of this date by Clerk of Court. [295736]
2016-01-11 73 0 TENDERED Title: OPENING BRIEF. Service: 01/11/2016 by email. [301945]
2016-01-11 74 0 BRIEF FILED for Cross-Appellant Hospira, Inc. [73]. Number of Pages: 56. Service: 01/11/2016 by email. Pursuant to ECF-10, filer is directed to file thirty copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/19/2016. [302181] 2016-01-15 12:09:25 a16fe6c59496e121a9567456e48f5c6b825e955c
2016-01-19 76 0 Entry of appearance for Doris Johnson Hines as principal counsel for American Intellectual Property Law Association. Service: 01/19/2016 by email. [303736]
2016-01-19 77 0 Entry of appearance for Denise W. DeFranco as of counsel for American Intellectual Property Law Association. Service: 01/19/2016 by email. [303786]
2016-01-19 78 0 Entry of appearance for David K. Mroz as of counsel for American Intellectual Property Law Association. Service: 01/19/2016 by email. [303791]
2016-01-19 79 0 Entry of appearance for Erin M. Sommers as of counsel for American Intellectual Property Law Association. Service: 01/19/2016 by email. [303796]
2016-01-19 80 0 TENDERED from American Intellectual Property Law Association Title: AMICUS CURIAE BRIEF. Service: 01/19/2016 by email. [304366]
2016-01-19 81 0 AMICUS BRIEF FILED for AIPLA [80]. Number of Pages: 24. Service: 01/19/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/25/2016. [304782]
2016-01-21 82 0 Certificate of Interest for the Amicus Curiae AIPLA. Service: 01/21/2016 by email. [304891]
2016-02-03 86 0 TENDERED from Miller Patti Pershern PLLC Title: AMICUS CURIAE BRIEF. Service: 02/03/2016 by email. [308351]
2016-02-05 88 0 MOTION of Intellectual Property Owners Association for leave to file an amicus curiae brief. Response/Opposition is due 02/19/2016, to extend the time to 02/05/2016 to file the amicus curiae brief. Response/Opposition is due 02/19/2016 [Consent: unopposed]. Service: 02/05/2016 by email. [308995]
2016-02-05 89 0 TENDERED from Intellectual Property Owners Association Title: AMICUS CURIAE BRIEF. Service: 02/05/2016 by email. [308997]
2016-02-05 90 0 Entry of appearance for Emily C. Johnson as principal counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [308998]
2016-02-05 91 0 Entry of appearance for Michael P. Kahn as of counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [308999]
2016-02-05 92 0 Entry of appearance for Mark W. Lauroesch as of counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [309000]
2016-02-05 93 0 Entry of appearance for Steven W. Miller as of counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [309001]
2016-02-05 94 0 Entry of appearance for Kevin H. Rhodes as of counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [309002]
2016-02-05 95 0 Entry of appearance for James E. Tysse as of counsel for Intellectual Property Owners Association. Service: 02/05/2016 by email. [309004]
2016-02-10 97 0 NOTICE OF REJECTION: The brief of Miller Patti Pershern PLLC , Amicus Brief [86], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by Clerk of Court. [309874]
2016-02-10 98 0 Entry of appearance for Anthony P. Miller as principal counsel for Miller Patti Pershern PLLC. Service: 02/10/2016 by email. [310090]
2016-02-10 99 0 Entry of appearance for S. Scott Pershern as of counsel for Miller Patti Pershern PLLC. Service: 02/10/2016 by email. [310094]
2016-02-10 100 0 Entry of appearance for John J. Patti as of counsel for Miller Patti Pershern PLLC. Service: 02/10/2016 by email. [310096]
2016-02-11 101 0 ORDER filed granting motion for leave to file an amicus curiae brief [88]; granting motion to extend time to file amicus brief [88].. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [310183]
2016-02-05 102 0 AMICUS BRIEF FILED for Intellectual Property Owners Association [89]. Number of Pages: 14. Service: 02/05/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/16/2016. [310210]
2016-02-03 103 0 AMICUS BRIEF FILED for Miller, Patti, Pershern PLLC [86]. Number of Pages: 19. Service: 02/03/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/16/2016. [310314]
2016-02-12 104 0 Certificate of Interest for the Amicus Curiae Intellectual Property Owners Association. Service: 02/12/2016 by email, US mail. [310870]
2016-02-22 105 0 Entry of appearance for Jason A. Kanter as of counsel for Appellant The Medicines Company. Service: 02/22/2016 by email. [312923]
2016-02-22 106 0 Entry of appearance for Laura E. Krawczyk as of counsel for Appellant The Medicines Company. Service: 02/22/2016 by email. [312928]
2016-02-22 107 0 Corrected Entry of appearance for Jason A. Kanter as of counsel for Appellant The Medicines Company. Service: 02/22/2016 by email. [312966]
2016-02-22 108 0 Corrected Entry of appearance for Laura E. Krawczyk as of counsel for Appellant The Medicines Company. Service: 02/22/2016 by email. [312971]
2016-02-24 109 0 Entry of appearance for Damon M. Lewis as of counsel for Appellant The Medicines Company. Service: 02/24/2016 by email. [313621]
2016-02-24 110 0 TENDERED from Appellant The Medicines Company. Title: RESPONSE BRIEF. Service: 02/24/2016 by email. [313712]
2016-02-25 112 0 Entry of appearance for C. Sebastian Zonte as of counsel for Appellant The Medicines Company. Service: 02/25/2016 by email. [314031]
2016-02-24 114 0 BRIEF FILED for Appellant The Medicines Company [110]. Number of Pages: 56. Service: 02/24/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format.. [314487]
2016-03-01 116 0 Entry of appearance for Tamsen Valoir as principal counsel for Houston Intellectual Property Law Association. Service: 03/01/2016 by email, US mail. [314861]
2016-03-01 117 0 Entry of appearance for Thomas W. Krause as of counsel for Amicus Curiae US. Service: 03/01/2016 by email. [315011]
2016-03-01 118 0 Entry of appearance for Joseph G. Piccolo as of counsel for Amicus Curiae US. Service: 03/01/2016 by email, US mail. [315019]
2016-03-01 119 0 Entry of appearance for Kristi L. R. Sawert as of counsel for Amicus Curiae US. Service: 03/01/2016 by email. [315027]
2016-03-01 120 0 Entry of appearance for Robert E. McBride as of counsel for Amicus Curiae US. Service: 03/01/2016 by email. [315035]
2016-03-01 121 0 TENDERED from Houston Intellectual Property Law Association Title: AMICUS CURIAE BRIEF. Service: 03/01/2016 by email, US mail. [315139]
2016-03-01 122 0 Corrected Entry of appearance for Tamsen Valoir as principal counsel for Houston Intellectual Property Law Association. Service: 03/01/2016 by email, US mail. [315140]
2016-03-01 123 0 Entry of appearance for Mark J. Gatschet as of counsel for Houston Intellectual Property Law Association. Service: 03/01/2016 by email, US mail. [315141]
2016-03-01 124 0 AMICUS BRIEF FILED for Houston Intellectual Property Law Association [121]. Number of Pages: 29. Service: 03/01/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/07/2016. [315274]
2016-03-02 125 0 Entry of appearance for Eric J. Marandett as principal counsel for Biotechnology Innovation Organization. Service: 03/02/2016 by email. [315332]
2016-03-02 126 0 Entry of appearance for Irene Oberman Khagi as of counsel for Biotechnology Innovation Organization. Service: 03/02/2016 by email. [315333]
2016-03-02 127 0 TENDERED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 03/02/2016 by email. [315334] 2016-07-11 17:26:55 e195d75243448650fe54d464d08a1c65926f9040
2016-03-02 128 0 AMICUS BRIEF FILED for Biotechnology Innovation Organization [127]. Number of Pages: 20. Service: 03/02/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/07/2016. [315432]
2016-03-02 129 0 Entry of appearance for Roberta J. Morris as principal counsel for Roberta J. Morris, Esq., Ph.D. Service: 03/02/2016 by email, US mail. [315448]
2016-03-02 130 0 Duplicate Entry of appearance for Roberta J. Morris as principal counsel for Roberta J. Morris, Esq., Ph.D.. Service: 03/02/2016 by email, US mail. [315465]
2016-03-02 131 0 Certificate of Interest for the Amicus Curiae Biotechnology Innovation Organization. Service: 03/02/2016 by email. [315471]
2016-03-02 132 0 TENDERED from The United States Title: AMICUS CURIAE BRIEF. Service: 03/02/2016 by email. [315498]
2016-03-02 133 0 Entry of appearance for Craig E. Countryman as principal counsel for Gilead Sciences, Inc.. Service: 03/02/2016 by email. [315524]
2016-03-02 134 0 Entry of appearance for Jonathan Singer as of counsel for Gilead Sciences, Inc.. Service: 03/02/2016 by email. [315526]
2016-03-02 135 0 Entry of appearance for Jared A. Smith as of counsel for Gilead Sciences, Inc.. Service: 03/02/2016 by email. [315528]
2016-03-02 136 0 TENDERED from Gilead Sciences, Inc. Title: AMICUS CURIAE BRIEF. Service: 03/02/2016 by email. [315529] 2016-07-11 17:34:44 4a841c461bfbc20250018de07e589e0affe46f95
2016-03-02 137 0 Entry of appearance for Bruce M. Wexler as principal counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315530]
2016-03-02 138 0 Entry of appearance for Joseph M. O'Malley as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315531]
2016-03-02 139 0 Entry of appearance for Eric W. Dittmann as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315532]
2016-03-02 140 0 Entry of appearance for Young J. Park as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315533]
2016-03-02 141 0 Entry of appearance for Stephen B. Kinnaird as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315534]
2016-03-02 142 0 Entry of appearance for Anand B. Patel as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/02/2016 by email. [315536]
2016-03-02 143 0 TENDERED from Pharmaceutical Research and Manufacturers of America Title: AMICUS CURIAE BRIEF. Service: 03/02/2016 by email. [315537] 2016-07-11 17:41:54 74a36243cb13074b93cd7be0ccc08584291e562e
2016-03-02 144 0 TENDERED from Roberta J. Morris, Esq., Ph.D. Title: AMICUS CURIAE BRIEF. Service: 03/02/2016 by email. [315547]
2016-03-02 145 0 AMICUS BRIEF FILED for Gilead Sciences, Inc. [136]. Number of Pages: 18. Service: 03/02/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/08/2016. [315610]
2016-03-02 148 0 AMICUS BRIEF FILED for Doctor Roberta Jean Morris, Esq. [144]. Number of Pages: 14. Service: 03/02/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/08/2016. [315653]
2016-03-02 150 0 AMICUS BRIEF FILED for US [132]. Number of Pages: 27. Service: 03/02/2016 by email. Pursuant to ECF-10, filer is directed to file thirty copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/08/2016. [315716]
2016-03-03 151 0 Entry of appearance for David E. Korn as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/03/2016 by email. [315803]
2016-03-03 152 0 Entry of appearance for James M. Spears as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/03/2016 by email. [315804]
2016-03-03 153 0 Corrected Entry of appearance for David E. Korn as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/03/2016 by email. [315835]
2016-03-04 154 0 AMICUS BRIEF FILED for Pharmaceutical Research and Manufacturers of America [143]. Number of Pages: 27. Service: 03/02/2016 by email. Pursuant to ECF-10, filer is directed to file 30 copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/09/2016. [316089]
2016-03-09 160 0 NOTICE OF REJECTION: The paper brief of Amicus Curiae Doctor Roberta Jean Morris, Esq. [159], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by Clerk of Court. [317277]
2016-03-11 161 0 ORDER filed scheduling oral argument for May 5, 2016 at 10:00 a.m. in courtroom 201. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [317875]
2016-03-14 165 0 TENDERED from Cross-Appellant Hospira, Inc.. Title: REPLY BRIEF. Service: 03/14/2016 by email. [318500]
2016-03-14 166 0 REPLY BRIEF FILED for Cross-Appellant Hospira, Inc. [165]. Number of Pages: 29. Service: 03/14/2016 by email. Pursuant to ECF-10, filer is directed to file thirty copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/21/2016. [318789]
2016-03-21 169 0 TENDERED from Cross-Appellant Hospira, Inc.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 03/21/2016 by email. [320400]
2016-03-21 170 0 APPENDIX FILED (SUPPLEMENTAL) for Hospira, Inc. [169]. Number of Pages: 42. Service: 03/21/2016 by email. Pursuant to ECF-10, filer is directed to file thirty copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/28/2016. [320512]
2016-03-29 174 0 MOTION of Amicus Curiae US for Leave to Participate in Oral Argument. Response/Opposition is due 04/11/2016 [Consent: unopposed]. Service: 03/29/2016 by email. [322364]
2016-03-31 176 0 ORDER filed granting motion for leave to participate in oral argument [174] filed by Amicus Curiae US. The United States will have 10 minutes of argument time, ceded from the appellant, The Medicines Company. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [323011]
2016-04-15 181 0 Entry of appearance for Joshua M. Segal as of counsel for Cross-Appellant Hospira, Inc.. Service: 04/15/2016 by email, US mail. [326791]
2016-04-18 182 0 Amended Certificate of Interest for the Cross-Appellant Hospira, Inc.. Service: 04/18/2016 by email, US mail. [327316]
2016-07-11 184 0 OPINION filed. The judgment or decision is: Affirmed-in-Part and Remanded to the Merits Panel. (Precedential Opinion). (For the Court: Prost,Chief Judge; Newman,Circuit Judge; Lourie,Circuit Judge; Dyk,Circuit Judge; Moore,Circuit Judge; O'Malley,Circuit Judge; Reyna,Circuit Judge; Wallach,Circuit Judge; Taranto,Circuit Judge; Chen,Circuit Judge; Hughes,Circuit Judge and Stoll,Circuit Judge). [349658] [14-1469, 14-1504] --[Edited 07/11/2016 by clerk to correct docket text and the opinion cover letter to indicate that the judgment has not issued.]
2014-08-13 0130346677 0 TENDERED from Appellant The Medicines Company. Title: OPENING BRIEF. Service: 08/13/2014 by email. [174989]
2014-09-26 0130370128 0 TENDERED from Cross-Appellant Hospira, Inc.. Title: OPENING BRIEF. Service: 09/26/2014 by email. [185947]